Increasing Access to Fertility Preservation for Women with Breast Cancer
Recruiting
N/A
Interventional Study
Breast Cancer
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 40
- Sex
- Female
- Study type
- Interventional
- Purpose
- Other
- Participants needed
- 750 (estimated)
- Sponsor
- University Paul Sabatier of Toulouse · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The EVAPREF project aims to increase access to fertility preservation by developing an approach to improve and evaluate existing information and coordination tools developed by the Pays-de-la-Loire and Occitanie Regional Cancer networks. First, the investigators will use a qualitative, iterative, user-centered and participatory approach to improve the current tools and create training content for …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients over 18 and under 40 years of age treated for newly diagnosed breast cancer and receiving chemotherapy.
* People who are able to read the study information poster and the fertility preservation information brochure in French, either alone or with help from a caregiver…
Contacts